Fabien Zunino

Title: Fabien Zunino: Innovator in Medicinal Chemistry

Introduction

Fabien Zunino is a notable inventor based in Buxerolles, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on various pharmaceutical compounds. With a total of 3 patents, Zunino's inventions focus on the development of new drugs with hypnotic and sedative effects.

Latest Patents

Zunino's latest patents include the following:

1. **Dihydroimidazo[5.1-a]-beta-carboline derivatives, method for their preparation, and their application as a drug**. This invention concerns dihydroimidazo[-a]-β-carboline compounds of general formula (I). The compounds feature various substituents, including hydrogen, halogen atoms, and alkyl groups, among others. These compounds are intended for use in medicine, particularly as hypnotics.

2. **Pyrrolo-(3,4-b)quinoline derivatives, method for the production and use thereof as a medicament**. This invention relates to pyrrolo[3,4-b]quinoline derivatives of general formula (I), where X can be an oxygen or sulfur atom. These derivatives exhibit hypnotic or sedative effects, making them valuable in therapeutic applications.

Career Highlights

Throughout his career, Fabien Zunino has worked with prominent companies in the pharmaceutical industry, including Pierre Fabre Medicament. His work has significantly impacted the development of new medicinal compounds, showcasing his expertise in the field.

Collaborations

Zunino has collaborated with esteemed colleagues such as Jean-Claude Jacquesy and Marie-Paule Jouannetaud. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Fabien Zunino's innovative contributions to medicinal chemistry highlight his role as a leading inventor in the field. His patents reflect a commitment to advancing pharmaceutical science and improving therapeutic options for patients.